Long-term Follow-up for Multidrug-resistant Tuberculosis

Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sonya S., Furin, Jennifer J., Alcántara, Felix, Bayona, Jaime, Sánchez, Epifanio, Mitnick, Carole D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294679/
https://www.ncbi.nlm.nih.gov/pubmed/16704823
http://dx.doi.org/10.3201/eid1204.041256